NCT04486482已完成不适用
An Exploratory, Open Label, Clinical Study to Evaluate the Physiologic Effects of KB109 in Adult Patients With Mild-to-Moderate COVID-19 on Gut Microbiota Structure and Function in the Outpatient Setting
Kaleido Biosciences24 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2021年1月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 49
- 试验地点
- 24
- 主要终点
- Number of patients experiencing study-product related treatment-emergent adverse events (TEAEs)
研究概览
简要总结
This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •To be considered for enrollment into this study, each patient must meet all of the following Inclusion Criteria:
- •Be male or female, ≥18 years of age
- •Be willing and able to give informed consent
- •Screening/Randomization telemedicine visit within 2 days of testing positive test for COVID-19
- •Having self-reported fever or cough for not more than 72 hours prior to COVID-19 testing
- •Mild to moderate COVID-19
- •Able to adhere to the study visit schedule and other protocol requirements
- •Patients who meet any of the following
排除标准
- •at the Randomization Visit will not be enrolled into the study:
- •Patients who are hospitalized for in-patient treatment or currently being evaluated for potential hospitalization at the time of informed consent for conditions other than COVID-19
- •History of chronic lung disease
- •Ongoing requirement for oxygen therapy
- •Shortness of breath in resting position
- •Diagnosis of sleep apnea requiring Bilevel Positive Airway Pressure (BIPAP) / Continuous Positive Airway Pressure (CPAP)
- •Female patients who are pregnant, trying to become pregnant or lactating.
- •Is considered, in the opinion of the PI, to be unlikely for any reason to be able to comply with study procedures
结局指标
主要结局
Number of patients experiencing study-product related treatment-emergent adverse events (TEAEs)
时间窗: Day 1 to Day 35
次要结局
- Relative abundance of microbial taxa in fecal samples as assessed by shotgun profiling based on shotgun sequencing.(Day 1 to Day 35)
研究者
研究点 (24)
Loading locations...
相似试验
终止
不适用
VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant OrganismsVancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized SubjectsNCT03944369Kaleido Biosciences3
已完成
不适用
A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and FunctionUlcerative ColitisNCT04508413Kaleido Biosciences12
招募中
1 期
A Study of AK109 Combined With AK104 in Patients With Advanced Solid TumorsAdvanced Solid TumorNCT05142423Akeso198
已完成
2 期
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerOvarian NeoplasmNCT00494442AstraZeneca58
已完成
2 期
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)AsthmaNCT02720081Merck Sharp & Dohme LLC142